Publication Cover
Archives of Physiology and Biochemistry
The Journal of Metabolic Diseases
Volume 128, 2022 - Issue 6
128
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

MiRNA-6089 inhibits rheumatoid arthritis fibroblast-like synoviocytes proliferation and induces apoptosis by targeting CCR4

, , , , , , & show all
Pages 1426-1433 | Received 29 Mar 2020, Accepted 20 May 2020, Published online: 17 Jun 2020
 

Abstract

Several studies have suggested that fibroblast-like synoviocytes (FLSs) and miRNAs are implicated in the pathogenesis of rheumatoid arthritis (RA). This study was aimed to evaluate the function of miR-6089 in the regulation of RA-FLSs. The levels of miR-6089 were detected to be significantly lower in the synovial tissues and FLSs of RA than in the healthy synovial tissues and FLSs. The miR-6089 up-regulation in RA-FLSs significantly inhibited the proliferation and promoted cell apoptosis accompany with an increase protein expression of cleaved-Caspase-3, -8 and -9. Furthermore, CCR4 was determined to target miR-6089 directly, and its expression was significantly increased in the synovial tissues of RA than in the healthy synovial tissues. The overexpression of CCR4 reversed the effect of miR-6089 on proliferation and apoptosis in RA-FLSs effectively. In conclusion, our study suggests that the miR-6089 may be a potential target for prevention and treatment of RA.

Author contributions

S.L. wrote the manuscript and operated the experiments; Z.Z., S.W., Y.L., and M.Y. operated molecular experiments; P.C. and M.W. analysed the data; S.L. and M.W. designed the experiments and edited the manuscript. S.L. and C.L. revised the manuscript.

Disclosure statement

No potential conflict of interest has been reported by the author(s).

Date availability statement

All the required data are present in the article.

Additional information

Funding

This study was supported by Wenzhou Science and Technology Bureau Project [Y20160301 and 2017Y0539].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.